More than 80% of children newly diagnosed with acute lymphoblastic leukaemia (ALL) are successfully treated today – an achievement deemed by Dr Michael Osborn as “one of the true success stories of modern medicine”.
When Nikita was born with leukaemia in August 2019 his parents were told he probably wouldn’t survive; his chances being only 4%.
Professor David Curtis has focused his research on searching for new ways to treat early T-cell precursor acute lymphoblastic leukaemia (ETP-ALL) which he describes as “a nasty type of leukaemia”.
The ability to use haploidentical donors, or half matched donors, is the most important recent development in stem cell transplantation, says world leader in transplant research, Professor David Curtis.
A clinical trial, due to open in mid-2022, will give young people access to two promising new ALL drugs.
Mother and psychologist, Sandra Evans shares the story of when her eldest daughter, Tahlia was diagnosed with acute lymphoblastic leukaemia at age four. Sandra discusses how she and her husband, Randall, managed their broader family and finances. She recounts the time of diagnosis and treatment, and her experiences with doctors.
Zoe Li was a healthy baby when she was born, but five weeks later her parents were told the shocking news… she had leukaemia.
Helen has no idea how many kilometres she walked with her beloved pooch Prinnie for over 15 years collecting for the Leukaemia Foundation Doorknock campaign. But she does know every step was worth it to help save the lives of children with blood cancer – like her young friend, Rachel, who was diagnosed with leukaemia in 1991.
After beating blood cancer and becoming a first-time dad, Will decided to take care of his mental health.
